Real-time enrollment status for this central nervous system lymphoma clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT04906902 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Central Nervous System Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 49 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | February 20, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT04906902 is currently active_not_recruiting participants. This clinical trial study for central nervous system lymphoma is not currently accepting new participants at 3 locations across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04906902 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04906902 was last updated 1 week ago (February 20, 2026). HelloStudys verifies this status automatically.